Daniel L. Dunkelmann

Daniel L. Dunkelmann

Auto-generated profile, based on publicly available information

Daniel L. Dunkelmann

Medical Research Council Laboratory of Molecular Biology, Cambridge, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


29 August 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
TPToby Passioura
Toby Passioura
WLWenyu Liu
Wenyu Liu
DDDaniel Dunkelmann
Daniel Dunkelmann
THTakashi Higuchi
Takashi Higuchi
HSHiroaki Suga
Hiroaki Suga

10 January 2024 in Nature
Verified
Journal Article
Open access
PDF file
DDDaniel L. Dunkelmann
Daniel L. Dunkelmann
CPCarlos Piedrafita
Carlos Piedrafita
ADAlexandre Dickson
Alexandre Dickson
KLKim C. Liu
Kim C. Liu
TEThomas S. Elliott
Thomas S. Elliott
JCJason W. Chin
Jason W. Chin
The genetic code of living cells has been reprogrammed to enable the site-specific incorporation of hundreds of non-canonical amino acids into proteins, and the encoded synthesis of non-canonical polymers and macrocyclic peptides and depsipeptides1–3. Current methods for engineering orthogonal aminoacyl-tRNA synthetases to acylate new monomers, as required for the expansion and reprogramming of the genetic code, rely on translational readouts and therefore require the monomers to be ribosomal substrates4–6. Orthogonal synthetases cannot be evolved to acylate orthogonal tRNAs with non-canonical monomers (ncMs) that are poor ribosomal substrates, and ribosomes cannot be evolved to polymerize ncMs that cannot be acylated onto orthogonal tRNAs—this co-dependence creates an evolutionary deadlock that has essentially restricted the scope of translation in living cells to α-l-amino acids and closely related hydroxy acids. Here we break this deadlock by developing tRNA display, which enables direct, rapid and scalable selection for orthogonal synthetases that selectively acylate their cognate orthogonal tRNAs with ncMs inEscherichia coli, independent of whether the ncMs are ribosomal substrates. Using tRNA display, we directly select orthogonal synthetases that specifically acylate their cognate orthogonal tRNA with eight non-canonical amino acids and eight ncMs, including several β-amino acids, α,α-disubstituted-amino acids and β-hydroxy acids. We build on these advances to demonstrate the genetically encoded, site-specific cellular incorporation of β-amino acids and α,α-disubstituted amino acids into a protein, and thereby expand the chemical scope of the genetic code to new classes of monomers.

26 April 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
JMJames I. Murray
James I. Murray
NFNils J. Flodén
Nils J. Flodén
ABAdriano Bauer
Adriano Bauer
NFNico Dennis Fessner
Nico Dennis Fessner
DDDaniel L. Dunklemann
Daniel L. Dunklemann
ASAlan Spivey
Alan Spivey
The first catalytic kinetic resolution by N‐sulfonylation is described. 2‐Substituted indolines are resolved (s=2.6–19) using an atropisomeric 4‐dimethylaminopyridine‐N‐oxide (4‐DMAP‐N‐oxide) organocatalyst. Use of 2‐isopropyl‐4‐nitrophenylsulfonyl chloride is critical to the stereodiscrimination and enables facile deprotection of the sulfonamide products with thioglycolic acid. A qualitative model that accounts for the stereodiscrimination is proposed.

20 April 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MPMoritz Pott
Moritz Pott
MTMatthias Tinzl
Matthias Tinzl
THTakahiro Hayashi
Takahiro Hayashi
YOYusuke Ota
Yusuke Ota
DDDaniel Dunkelmann
Daniel Dunkelmann
DHDonald Hilvert
Donald Hilvert